131 related articles for article (PubMed ID: 2846422)
1. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.
Wargotz ES; Silverberg SG
Hum Pathol; 1988 Nov; 19(11):1340-6. PubMed ID: 2846422
[TBL] [Abstract][Full Text] [Related]
2. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Eur J Cancer; 1995 Dec; 31A(13-14):2289-95. PubMed ID: 8652258
[TBL] [Abstract][Full Text] [Related]
3. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.
Gaffey MJ; Mills SE; Frierson HF; Zarbo RJ; Boyd JC; Simpson JF; Weiss LM
Mod Pathol; 1995 Jan; 8(1):31-8. PubMed ID: 7731939
[TBL] [Abstract][Full Text] [Related]
4. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.
Rapin V; Contesso G; Mouriesse H; Bertin F; Lacombe MJ; Piekarski JD; Travagli JP; Gadenne C; Friedman S
Cancer; 1988 Jun; 61(12):2503-10. PubMed ID: 2835145
[TBL] [Abstract][Full Text] [Related]
5. Mucinous breast carcinoma and mixed mucinous-infiltrating ductal carcinoma: a comparative cytologic study.
Stanley MW; Tani EM; Skoog L
Diagn Cytopathol; 1989; 5(2):134-8. PubMed ID: 2550188
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
Cook DL; Weaver DL
Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
[TBL] [Abstract][Full Text] [Related]
7. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
Gaffey MJ; Frierson HF; Mills SE; Boyd JC; Zarbo RJ; Simpson JF; Gross LK; Weiss LM
Mod Pathol; 1993 Nov; 6(6):721-8. PubMed ID: 8302815
[TBL] [Abstract][Full Text] [Related]
8. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Br J Cancer; 1991 Apr; 63(4):591-5. PubMed ID: 2021545
[TBL] [Abstract][Full Text] [Related]
9. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
10. Prognostic comparison of three classifications for medullary carcinomas of the breast.
Jensen ML; Kiaer H; Andersen J; Jensen V; Melsen F
Histopathology; 1997 Jun; 30(6):523-32. PubMed ID: 9205856
[TBL] [Abstract][Full Text] [Related]
11. The prognostic importance of syncytial growth pattern in medullary carcinoma of the breast.
Pedersen L; Schiødt T; Holck S; Zedeler K
APMIS; 1990 Oct; 98(10):921-6. PubMed ID: 2245011
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate.
Kleer CG; Michael CW
Diagn Cytopathol; 2000 Jul; 23(1):39-42. PubMed ID: 10907931
[TBL] [Abstract][Full Text] [Related]
13. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
[TBL] [Abstract][Full Text] [Related]
14. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
J Surg Oncol; 2016 Oct; 114(5):533-536. PubMed ID: 27393599
[TBL] [Abstract][Full Text] [Related]
15. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
[TBL] [Abstract][Full Text] [Related]
16. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
17. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
[TBL] [Abstract][Full Text] [Related]
18. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
[TBL] [Abstract][Full Text] [Related]
19. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]